You searched for "malignant"

259 results found

Head and neck cancer multidisciplinary team

Why do we have MDTs? Do they make a difference to outcomes? Jon Bernstein explores the whys and wherefores of the head and neck cancer MDT, and wonders where things might go from here… Head and neck (upper aerodigestive tract)...

The future of rhinology

Over the last few decades, rhinology has been one of the most dynamic and progressive areas of ENT. Professor Fokkens is perfectly placed to offer insight into the future possibilities that could transform our patients’ care, many of which are...

In conversation with Trevor McGill

After more than four decades of paediatric clinical practice, Trevor McGill shares his wealth of experience and knowledge with Pat Bradley. Trevor, as a national and internationally acknowledged Paediatric Oto-Rhino-Laryngologist, Head and Neck Surgeon, to what do you owe this...

Head and neck cancer deaths to cost $535 billion by 2030

More than 500,000 people across the globe will die this year from head and neck cancer, which is the sixth most common cancer in the world and comprises malignancies of the nose, mouth, throat, larynx, and neck. Assuming current trends...

In conversation with Prof Metin Önerci

Prof Valerie Lund caught up with friend and colleague, Prof Dr Metin Önerci, to discuss his various positions in rhinology, the FOAM programme with which he is involved, and rhinology in Turkey and the Balkan and the Central Asian region....

International Federation of Head and Neck Oncologic Societies

IHNOS Head and Neck Cancer Summit

The future of head and neck cancer surgery

Neil Sharma paints an exciting picture of the future of head and neck surgery with nanobots and robot augmented humans – science fiction or reality? Time will tell. ‘May you live in interesting times’ reads the old Chinese curse. The...